Global Plasma-derived Medicinal Products Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 103

Published Date: 08 Sep 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Plasma-derived Medicinal Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Plasma-derived Medicinal Products size is estimated to be  million in 2021 from USD  million in 2020, with a change of  % between 2020 and 2021. The global Plasma-derived Medicinal Products market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Plasma-derived Medicinal Products market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Immunoglobulins
    Coagulation Factor Concentrates
    Other

Market segment by Application can be divided into
    Emergency Care
    Epidemic Diseasae
    Immune System Disorder
    Antibody Deficiency
    Coagulation Disorder
    Others

The key market players for global Plasma-derived Medicinal Products market are listed below:
    Novartis(CSL Limited)
    Biotest AG (Creat Group Corporation)
    Grifols SA
    Sigma-Aldrich
    Thermo Fisher Scientific
    Octapharma AG
    Takeda
    Kedrion
    China Biologic Products
    LFB Group

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Plasma-derived Medicinal Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma-derived Medicinal Products, with price, sales, revenue and global market share of Plasma-derived Medicinal Products from 2019 to 2021.
Chapter 3, the Plasma-derived Medicinal Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma-derived Medicinal Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Plasma-derived Medicinal Products market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Plasma-derived Medicinal Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Plasma-derived Medicinal Products Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Plasma-derived Medicinal Products Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Immunoglobulins
        1.2.3 Coagulation Factor Concentrates
        1.2.4 Other
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Plasma-derived Medicinal Products Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Emergency Care
        1.3.3 Epidemic Diseasae
        1.3.4 Immune System Disorder
        1.3.5 Antibody Deficiency
        1.3.6 Coagulation Disorder
        1.3.7 Others
    1.4 Global Plasma-derived Medicinal Products Market Size & Forecast
        1.4.1 Global Plasma-derived Medicinal Products Sales in Value (2016-2026))
        1.4.2 Global Plasma-derived Medicinal Products Sales in Volume (2016-2026)
        1.4.3 Global Plasma-derived Medicinal Products Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Plasma-derived Medicinal Products Production Capacity Analysis
        1.5.1 Global Plasma-derived Medicinal Products Total Production Capacity (2016-2026)
        1.5.2 Global Plasma-derived Medicinal Products Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Plasma-derived Medicinal Products Market Drivers
        1.6.2 Plasma-derived Medicinal Products Market Restraints
        1.6.3 Plasma-derived Medicinal Products Trends Analysis

2 Manufacturers Profiles
    2.1 Novartis(CSL Limited)
        2.1.1 Novartis(CSL Limited) Details
        2.1.2 Novartis(CSL Limited) Major Business
        2.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Product and Services
        2.1.4 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Biotest AG (Creat Group Corporation)
        2.2.1 Biotest AG (Creat Group Corporation) Details
        2.2.2 Biotest AG (Creat Group Corporation) Major Business
        2.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product and Services
        2.2.4 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Grifols SA
        2.3.1 Grifols SA Details
        2.3.2 Grifols SA Major Business
        2.3.3 Grifols SA Plasma-derived Medicinal Products Product and Services
        2.3.4 Grifols SA Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Sigma-Aldrich
        2.4.1 Sigma-Aldrich Details
        2.4.2 Sigma-Aldrich Major Business
        2.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Product and Services
        2.4.4 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Thermo Fisher Scientific
        2.5.1 Thermo Fisher Scientific Details
        2.5.2 Thermo Fisher Scientific Major Business
        2.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Product and Services
        2.5.4 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Octapharma AG
        2.6.1 Octapharma AG Details
        2.6.2 Octapharma AG Major Business
        2.6.3 Octapharma AG Plasma-derived Medicinal Products Product and Services
        2.6.4 Octapharma AG Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Takeda
        2.7.1 Takeda Details
        2.7.2 Takeda Major Business
        2.7.3 Takeda Plasma-derived Medicinal Products Product and Services
        2.7.4 Takeda Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Kedrion
        2.8.1 Kedrion Details
        2.8.2 Kedrion Major Business
        2.8.3 Kedrion Plasma-derived Medicinal Products Product and Services
        2.8.4 Kedrion Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 China Biologic Products
        2.9.1 China Biologic Products Details
        2.9.2 China Biologic Products Major Business
        2.9.3 China Biologic Products Plasma-derived Medicinal Products Product and Services
        2.9.4 China Biologic Products Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 LFB Group
        2.10.1 LFB Group Details
        2.10.2 LFB Group Major Business
        2.10.3 LFB Group Plasma-derived Medicinal Products Product and Services
        2.10.4 LFB Group Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Plasma-derived Medicinal Products Sales by Manufacturer
    3.1 Global Plasma-derived Medicinal Products Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Plasma-derived Medicinal Products Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Plasma-derived Medicinal Products
    3.4 Market Concentration Rate
        3.4.1 Top 3 Plasma-derived Medicinal Products Manufacturer Market Share
        3.4.2 Top 6 Plasma-derived Medicinal Products Manufacturer Market Share
    3.5 Global Plasma-derived Medicinal Products Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Plasma-derived Medicinal Products Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Plasma-derived Medicinal Products Market Size by Region
        4.1.1 Global Plasma-derived Medicinal Products Sales in Volume by Region (2016-2026)
        4.1.2 Global Plasma-derived Medicinal Products Revenue by Region (2016-2026)
    4.2 North America Plasma-derived Medicinal Products Revenue (2016-2026)
    4.3 Europe Plasma-derived Medicinal Products Revenue (2016-2026)
    4.4 Asia-Pacific Plasma-derived Medicinal Products Revenue (2016-2026)
    4.5 South America Plasma-derived Medicinal Products Revenue (2016-2026)
    4.6 Middle East and Africa Plasma-derived Medicinal Products Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Plasma-derived Medicinal Products Sales in Volume by Type (2016-2026)
    5.2 Global Plasma-derived Medicinal Products Revenue by Type (2016-2026)
    5.3 Global Plasma-derived Medicinal Products Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Plasma-derived Medicinal Products Sales in Volume by Application (2016-2026)
    6.2 Global Plasma-derived Medicinal Products Revenue by Application (2016-2026)
    6.3 Global Plasma-derived Medicinal Products Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Plasma-derived Medicinal Products Sales by Type (2016-2026)
    7.2 North America Plasma-derived Medicinal Products Sales by Application (2016-2026)
    7.3 North America Plasma-derived Medicinal Products Market Size by Country
        7.3.1 North America Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
        7.3.2 North America Plasma-derived Medicinal Products Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Plasma-derived Medicinal Products Sales by Type (2016-2026)
    8.2 Europe Plasma-derived Medicinal Products Sales by Application (2016-2026)
    8.3 Europe Plasma-derived Medicinal Products Market Size by Country
        8.3.1 Europe Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
        8.3.2 Europe Plasma-derived Medicinal Products Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Plasma-derived Medicinal Products Sales by Type (2016-2026)
    9.2 Asia-Pacific Plasma-derived Medicinal Products Sales by Application (2016-2026)
    9.3 Asia-Pacific Plasma-derived Medicinal Products Market Size by Region
        9.3.1 Asia-Pacific Plasma-derived Medicinal Products Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Plasma-derived Medicinal Products Sales by Type (2016-2026)
    10.2 South America Plasma-derived Medicinal Products Sales by Application (2016-2026)
    10.3 South America Plasma-derived Medicinal Products Market Size by Country
        10.3.1 South America Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
        10.3.2 South America Plasma-derived Medicinal Products Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2016-2026)
    11.2 Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2016-2026)
    11.3 Middle East & Africa Plasma-derived Medicinal Products Market Size by Country
        11.3.1 Middle East & Africa Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Plasma-derived Medicinal Products Typical Distributors
    12.3 Plasma-derived Medicinal Products Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Plasma-derived Medicinal Products Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Plasma-derived Medicinal Products Revenue by Application, (USD Million), 2021-2026
    Table 3. Novartis(CSL Limited) Basic Information, Manufacturing Base and Competitors
    Table 4. Novartis(CSL Limited) Major Business
    Table 5. Novartis(CSL Limited) Plasma-derived Medicinal Products Product and Services
    Table 6. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Biotest AG (Creat Group Corporation) Basic Information, Manufacturing Base and Competitors
    Table 8. Biotest AG (Creat Group Corporation) Major Business
    Table 9. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product and Services
    Table 10. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Grifols SA Basic Information, Manufacturing Base and Competitors
    Table 12. Grifols SA Major Business
    Table 13. Grifols SA Plasma-derived Medicinal Products Product and Services
    Table 14. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
    Table 16. Sigma-Aldrich Major Business
    Table 17. Sigma-Aldrich Plasma-derived Medicinal Products Product and Services
    Table 18. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
    Table 20. Thermo Fisher Scientific Major Business
    Table 21. Thermo Fisher Scientific Plasma-derived Medicinal Products Product and Services
    Table 22. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Octapharma AG Basic Information, Manufacturing Base and Competitors
    Table 24. Octapharma AG Major Business
    Table 25. Octapharma AG Plasma-derived Medicinal Products Product and Services
    Table 26. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Takeda Basic Information, Manufacturing Base and Competitors
    Table 28. Takeda Major Business
    Table 29. Takeda Plasma-derived Medicinal Products Product and Services
    Table 30. Takeda Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 32. Kedrion Major Business
    Table 33. Kedrion Plasma-derived Medicinal Products Product and Services
    Table 34. Kedrion Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. China Biologic Products Basic Information, Manufacturing Base and Competitors
    Table 36. China Biologic Products Major Business
    Table 37. China Biologic Products Plasma-derived Medicinal Products Product and Services
    Table 38. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 40. LFB Group Major Business
    Table 41. LFB Group Plasma-derived Medicinal Products Product and Services
    Table 42. LFB Group Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Global Plasma-derived Medicinal Products Sales by Manufacturer (2019-2021e) & (K Units)
    Table 44. Global Plasma-derived Medicinal Products Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 45. Market Position of Manufacturers in Plasma-derived Medicinal Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 46. Global Plasma-derived Medicinal Products Production Capacity by Company, (K Units): 2020 VS 2021
    Table 47. Head Office and Plasma-derived Medicinal Products Production Site of Key Manufacturer
    Table 48. Plasma-derived Medicinal Products New Entrant and Capacity Expansion Plans
    Table 49. Plasma-derived Medicinal Products Mergers & Acquisitions in the Past Five Years
    Table 50. Global Plasma-derived Medicinal Products Sales by Region (2016-2021e) & (K Units)
    Table 51. Global Plasma-derived Medicinal Products Sales by Region (2021-2026) & (K Units)
    Table 52. Global Plasma-derived Medicinal Products Revenue by Region (2016-2021e) & (USD Million)
    Table 53. Global Plasma-derived Medicinal Products Revenue by Region (2021-2026) & (USD Million)
    Table 54. Global Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
    Table 55. Global Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
    Table 56. Global Plasma-derived Medicinal Products Revenue by Type (2016-2021e) & (USD Million)
    Table 57. Global Plasma-derived Medicinal Products Revenue by Type (2021-2026) & (USD Million)
    Table 58. Global Plasma-derived Medicinal Products Price by Type (2016-2021e) & (US$/Unit)
    Table 59. Global Plasma-derived Medicinal Products Price by Type (2021-2026) & (US$/Unit)
    Table 60. Global Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
    Table 61. Global Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
    Table 62. Global Plasma-derived Medicinal Products Revenue by Application (2016-2021e) & (USD Million)
    Table 63. Global Plasma-derived Medicinal Products Revenue by Application (2021-2026) & (USD Million)
    Table 64. Global Plasma-derived Medicinal Products Price by Application (2016-2021e) & (US$/Unit)
    Table 65. Global Plasma-derived Medicinal Products Price by Application (2021-2026) & (US$/Unit)
    Table 66. North America Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
    Table 67. North America Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
    Table 68. North America Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
    Table 69. North America Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
    Table 70. North America Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
    Table 71. North America Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
    Table 72. North America Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
    Table 73. North America Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
    Table 74. Europe Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
    Table 75. Europe Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
    Table 76. Europe Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
    Table 77. Europe Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
    Table 78. Europe Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
    Table 79. Europe Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
    Table 80. Europe Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
    Table 81. Europe Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
    Table 82. Asia-Pacific Plasma-derived Medicinal Products Sales by Region (2016-2021e) & (K Units)
    Table 83. Asia-Pacific Plasma-derived Medicinal Products Sales by Region (2021-2026) & (K Units)
    Table 84. Asia-Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2021e) & (USD Million)
    Table 85. Asia-Pacific Plasma-derived Medicinal Products Revenue by Region (2021-2026) & (USD Million)
    Table 86. Asia-Pacific Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
    Table 87. Asia-Pacific Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
    Table 88. Asia-Pacific Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
    Table 89. Asia-Pacific Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
    Table 90. South America Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
    Table 91. South America Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
    Table 92. South America Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
    Table 93. South America Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
    Table 94. South America Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
    Table 95. South America Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
    Table 96. South America Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
    Table 97. South America Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
    Table 98. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
    Table 99. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
    Table 100. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
    Table 101. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
    Table 102. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
    Table 103. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
    Table 104. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
    Table 105. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
    Table 106. Direct Channel Pros & Cons
    Table 107. Indirect Channel Pros & Cons
    Table 108. Plasma-derived Medicinal Products Typical Distributors
    Table 109. Plasma-derived Medicinal Products Typical Customers
List of Figures
    Figure 1. Plasma-derived Medicinal Products Picture
    Figure 2. Global Plasma-derived Medicinal Products Sales Market Share by Type in 2020
    Figure 3. Immunoglobulins
    Figure 4. Coagulation Factor Concentrates
    Figure 5. Other
    Figure 6. Global Plasma-derived Medicinal Products Sales Market Share by Application in 2020
    Figure 7. Emergency Care
    Figure 8. Epidemic Diseasae
    Figure 9. Immune System Disorder
    Figure 10. Antibody Deficiency
    Figure 11. Coagulation Disorder
    Figure 12. Others
    Figure 13. Global Plasma-derived Medicinal Products Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 14. Global Plasma-derived Medicinal Products Market Size and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Plasma-derived Medicinal Products Sales (2016-2026) & (K Units)
    Figure 16. Global Plasma-derived Medicinal Products Price by Type (2016-2026) & (US$/Unit)
    Figure 17. Global Plasma-derived Medicinal Products Production Capacity (2016-2026) & (K Units)
    Figure 18. Global Plasma-derived Medicinal Products Production Capacity by Geographic Region: 2020 VS 2021
    Figure 19. Plasma-derived Medicinal Products Market Drivers
    Figure 20. Plasma-derived Medicinal Products Market Restraints
    Figure 21. Plasma-derived Medicinal Products Market Trends
    Figure 22. Global Plasma-derived Medicinal Products Sales Market Share by Manufacturer in 2020
    Figure 23. Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturer in 2020
    Figure 24. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 25. Top 3 Plasma-derived Medicinal Products Manufacturer (Revenue) Market Share in 2020
    Figure 26. Top 6 Plasma-derived Medicinal Products Manufacturer (Revenue) Market Share in 2020
    Figure 27. Global Plasma-derived Medicinal Products Sales Market Share by Region (2016-2026)
    Figure 28. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2026)
    Figure 29. North America Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
    Figure 30. Europe Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
    Figure 31. Asia-Pacific Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
    Figure 32. South America Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
    Figure 33. Middle East & Africa Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
    Figure 34. Global Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
    Figure 35. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2026)
    Figure 36. Global Plasma-derived Medicinal Products Price by Type (2016-2026) & (US$/Unit)
    Figure 37. Global Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
    Figure 38. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2026)
    Figure 39. Global Plasma-derived Medicinal Products Price by Application (2016-2026) & (US$/Unit)
    Figure 40. North America Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
    Figure 41. North America Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
    Figure 42. North America Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
    Figure 43. North America Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
    Figure 44. United States Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Canada Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Mexico Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
    Figure 48. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
    Figure 49. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
    Figure 50. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
    Figure 51. Germany Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. France Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. United Kingdom Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Russia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Italy Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Asia-Pacific Plasma-derived Medicinal Products Sales Market Share by Region (2016-2026)
    Figure 57. Asia-Pacific Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
    Figure 58. Asia-Pacific Plasma-derived Medicinal Products Sales Market Share by Region (2016-2026)
    Figure 59. Asia-Pacific Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2026)
    Figure 60. China Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Japan Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Korea Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. India Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Southeast Asia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Australia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South America Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
    Figure 67. South America Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
    Figure 68. South America Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
    Figure 69. South America Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
    Figure 70. Brazil Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Argentina Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
    Figure 73. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
    Figure 74. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
    Figure 75. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
    Figure 76. Turkey Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Egypt Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. South Africa Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Sales Channel: Direct Channel vs Indirect Channel
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis(CSL Limited)
Biotest AG (Creat Group Corporation)
Grifols SA
Sigma-Aldrich
Thermo Fisher Scientific
Octapharma AG
Takeda
Kedrion
China Biologic Products
LFB Group

Related Reports

Global Plasma-derived Medicinal Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Plasma-derived Medicinal Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Pharma & Healthcare

The Plasma-derived Medicinal Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

plasma derived medicinal products

Plasma-derived Medicinal Products

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>